Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A deep look at the SURPASS-2 randomization design, blinding strategy, estimand framework, comparator choice, and statistical approach, and what each decision means for how you should read the headline result.
Read clinical reviewA deep dive into cost-per-QALY models, payer-coverage realities, and individual patient value calculations derived from the SURPASS-2 head-to-head tirzepatide vs semaglutide 1 mg trial.
Read clinical reviewDeep dive into SURPASS-2 follow-up data on tirzepatide vs semaglutide 1 mg in type 2 diabetes, covering durability of A1C and weight effects, post-trial regression, and emerging safety signals.
Read clinical reviewDeep-dive into SURPASS-2 pre-specified and post-hoc subgroup analyses comparing tirzepatide vs semaglutide 1 mg across age, sex, BMI, race, and baseline biomarkers in type 2 diabetes.
Read clinical reviewA plain-English deep dive into the SURPASS-2 trial comparing tirzepatide to semaglutide 1 mg in type 2 diabetes, covering methodology, results, limitations, and clinical implications.
Read clinical review